5 startling numbers reveal the militarisation of U.S. drug policy

News

5 startling numbers reveal the militarisation of U.S. drug policy

3 July 2014

1,100 – The number of Americans that die each year due to violent crime caused by the drug war
This average death toll of Americans murdered in drug-related crimes is higher than the annual fatality rate of US soldiers in either the Afghanistan or Iraq war. In fact, according to an analytical study of FBI crime statistics, the Vietnam War is the only conflict in the past half-century that has been deadlier for Americans. Disturbingly, this figure doesn’t even take into account the numerous individuals who have been killed by law enforcement in drug-related raids.

$51 billion – The amount that the U.S. government spends each year on the war on drugs
This huge figure, which is $5 billion more than the average annual expenditure on the Afghanistan War, is primarily allocated to arming and training the increasingly militarised law enforcement. According to a report by the American Civil Liberties Union (ACLU), weaponry held by US counter-narcotic agencies for use against American drug suspects includes flashbang grenades, sniper rifles, and submachine guns. There is also an increased prevalence of drug-targeting SWAT teams using armoured personnel carriers – vehicles that were originally created to “transport infantry and provide protection from shrapnel and small arms fire on the battlefield.”

61 percent – The percentage of individuals targeted by drug-related SWAT raids who are people of color
The ACLU investigated the impact rates of SWAT teams in sixteen counties around the US, and in every single one, people of color were disproportionately targeted. In Allentown, PA, Latinos were 29 times more likely than white people to endure a SWAT raid, while Blacks in Burlington, NC, were 47 times more likely than whites to face this violence. This bias treatment is ongoing despite the rates of drug use and selling being comparable across racial lines.

Read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.